Tavin Deru, | |
775 N 200 E, Brigham City, UT 84302-1303 | |
(435) 723-7777 | |
Not Available |
Full Name | Tavin Deru |
---|---|
Gender | Male |
Speciality | Occupational Therapist |
Location | 775 N 200 E, Brigham City, Utah |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790281418 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 10429475-4201 (Utah) | Primary |
Provider Name | Independence Rehab Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1063781813 PECOS PAC ID: 0143478453 Enrollment ID: O20120911000750 |
News Archive
The worst of the global Zika virus outbreak may be over but many key questions remain, such as why the virus persists in certain tissues after the systemic infection has cleared; how does the immune system counteract the virus and protect against reinfection; what determines the likelihood of long-term complications?
A majority (58%) of Americans believe that the H1N1 flu is a serious health hazard, according to a new survey released today by Silverlink Communications, Inc. This represents a marked increase as compared to May 2009, when 47% of Americans held this same perception of H1N1. While most Americans believe H1N1 is a serious health hazard, less than one-third (31%) of Americans plan on getting the H1N1 flu vaccine this year, with safety and efficacy of the vaccine cited as primary barriers for not getting the vaccine. Of particular concern, less than 27% of 18 to 24 year olds, a high risk group, plan on getting the H1N1 vaccine.
Writing in Humanosphere, development blogger Tom Murphy describes a report from Population Services International and Devex that shows "some of the facts and trends on global health giving in a special edition of Impact Magazine."
A colonoscopy might cost you or your insurer a few hundred dollars — or several thousand, depending on which hospital or insurer you use.
Cell Medica, a leading cellular therapeutics company which develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, is pleased to announce an exclusive license agreement and research collaboration with the Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine (Houston, Texas), for the commercialization of an innovative cell-based treatment for cancers associated with the oncogenic Epstein Barr virus (EBV).
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Tavin Deru, 206 N 2100 W, Salt Lake City, UT 84116-4740 Ph: () - | Tavin Deru, 775 N 200 E, Brigham City, UT 84302-1303 Ph: (435) 723-7777 |
News Archive
The worst of the global Zika virus outbreak may be over but many key questions remain, such as why the virus persists in certain tissues after the systemic infection has cleared; how does the immune system counteract the virus and protect against reinfection; what determines the likelihood of long-term complications?
A majority (58%) of Americans believe that the H1N1 flu is a serious health hazard, according to a new survey released today by Silverlink Communications, Inc. This represents a marked increase as compared to May 2009, when 47% of Americans held this same perception of H1N1. While most Americans believe H1N1 is a serious health hazard, less than one-third (31%) of Americans plan on getting the H1N1 flu vaccine this year, with safety and efficacy of the vaccine cited as primary barriers for not getting the vaccine. Of particular concern, less than 27% of 18 to 24 year olds, a high risk group, plan on getting the H1N1 vaccine.
Writing in Humanosphere, development blogger Tom Murphy describes a report from Population Services International and Devex that shows "some of the facts and trends on global health giving in a special edition of Impact Magazine."
A colonoscopy might cost you or your insurer a few hundred dollars — or several thousand, depending on which hospital or insurer you use.
Cell Medica, a leading cellular therapeutics company which develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, is pleased to announce an exclusive license agreement and research collaboration with the Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine (Houston, Texas), for the commercialization of an innovative cell-based treatment for cancers associated with the oncogenic Epstein Barr virus (EBV).
› Verified 2 days ago
Jacob Raymond Bryan, MOTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 815 S 200 W, Brigham City, UT 84302 Phone: 435-723-5289 Fax: 435-723-0579 | |
Summit Hand Therapy Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1030 Medical Dr Ste B, Brigham City, UT 84302 Phone: 801-866-9766 Fax: 801-773-1553 | |
Jamie Mcintosh, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 984 Medical Dr Ste 3, Brigham City, UT 84302 Phone: 435-239-8104 Fax: 435-239-8415 |